Genetic and compound screens uncover factors modulating cancer cell response to indisulam
Z. Pogacar, K. Groot, F. Jochems, M. Dos Santos Dias, B. Morris, M. Roosen, L. Wardak, G. De Conti, A. Velds, C. Lieftink, R. L. Beijersbergen, R. Bernards, R. Leite de Oliveira
This study identifies genetic and compound factors that modulate cancer cell response to the drug indisulam, revealing therapeutic strategies for its clinical reuse.
bioRxiv · Dec 20, 2021Cancer Biology